Managing IR During a Financial Restatement or SEC Inquiry

Restatements are down, but the ones still happening are hitting bigger, more visible companies, and that shift is why IR functions can no longer treat a restatement or SEC inquiry as a one-off crisis to be improvised. Total restatements fell 18% in 2025 to 391, the second-lowest annual count in a twenty-year database, as the SPAC-driven spike of the early part of the decade finally worked its way out of the system. But large accelerated filers, the companies with the biggest market caps and the most analyst coverage, now account for 25.5% of restatements in 2025, the highest share since 2019. Fewer restatements, more exposure. That's the environment IR teams are actually operating in.

What investors lose, and when they start losing it

The GAO's often-cited figure, that restating companies see stock prices fall almost 10% on average, market-adjusted, in the two-day window around the initial announcement, understates what's really happening to shareholder value. Academic research has documented that markets can begin marking prices down before a restatement is ever announced, meaning the announcement-day drop may understate the full cumulative impact on shareholder value, enough to more than reverse whatever gains investors thought they'd captured from the originally overstated earnings.

Hertz is the case that shows how long this tail can run. The stock fell close to 10% on the day the restatement was announced. The SEC opened an investigation into the events surrounding it. Shareholders filed suit. By July 2015, more than a year after the initial announcement, the process had erased close to 40% of the stock's value. The first 8-K omitted that damage because it was filed before the investigation, shareholder suits, and the stock's decline had occurred.

The form of the disclosure matters too, and this is where IR has actual leverage. A "Big R" reissuance restatement, the kind that requires an Item 4.02 filing and an explicit statement that prior financials should no longer be relied upon, causes on average a 3% sharper stock price drop than a "little r" revision restatement. The market reads the disclosure mechanism itself as a severity signal before anyone has even read the substance. Which means the way IR frames and contextualizes that language, without softening the legal requirement, is not a cosmetic exercise. It's the first data point the market gets.

How a restatement or SEC inquiry unfolds (the procedural sequence IR must track)

Two tracks tend to run at once, and IR needs to know which one is driving the timeline at any given moment. There's the internal restatement process, audit committee review, auditor fieldwork, revised filings, and there's the SEC inquiry track, which can be triggered by the restatement or can precede it.

The SEC side has its own ladder, and each rung changes what IR is allowed to say. It starts with a Matter Under Inquiry, an informal investigation where the Staff has no subpoena power and cooperation is voluntary, though how a company behaves at this stage colors everything that follows. If it escalates, the Staff obtains a formal order authorizing subpoenas for documents and testimony, and the subject matter of that order typically isn't disclosed beyond what the order itself states. Next comes a Wells Notice, the Staff's signal that it intends to recommend enforcement action, which gives the company a chance to submit a written response before any formal recommendation reaches the Commission. Then the Commission decides: enforcement action, or dismissal. Three dismissals of enforcement actions against public companies have occurred under the current administration, two in the first half of FY 2026 and one in the first half of FY 2025, a pace unprecedented in at least sixteen years.

Layered onto that ladder are specific disclosure checkpoints IR has to track like a calendar. The Item 4.02 "do not rely" 8-K is mandatory for Big R restatements, and it's the single moment where trading halts, analyst model resets, and press coverage converge. Wells Notices are also commonly disclosed via 8-K, and one company's board stated publicly that "the results of the Investigation and the Wells Notice process and any corresponding enforcement action against the Company … are unknown at this time," which is the deliberately narrow model for the best language on record." That approach says what's true, bounds it, and stops. Filing deadline extensions and NT filings need the same treatment, communicating delay without adding fuel to speculation about why.

A regional financial holding company offers a live, current example of how messy this can get. On July 14, 2026, management recommended, and the Audit Committee agreed, that previously issued consolidated financial statements for fiscal years 2024 and 2025, plus the first quarter of 2026, should no longer be relied upon. The trigger: $2.8 million of deferred origination costs and $2.1 million of accrued interest that together caused a material understatement of provision expense. Multiple periods, a specific dollar figure, a specific accounting mechanism. That's the kind of granularity IR eventually has to be ready to discuss, even if not on day one.

The SEC enforcement environment IR is operating in right now

The current Commission has been explicit, per King & Spalding's analysis of FY 2025 results and the first six months of FY 2026, that its priorities are fraud enforcement, retail investor protection, and individual accountability, not volume for its own sake and not novel legal theories. That doesn't mean public company accounting and disclosure cases have receded. They remain a top priority category, and the Commission brought nearly as many such cases in January 2026 alone as it did in all of 2025 combined.

The comment letter data tells a similar story. MD&A, non-GAAP measures, segment reporting, and revenue recognition have drawn the most scrutiny in SEC comment letters in recent periods, and those are the same categories most likely to show up as the root cause in a restatement. Smaller registrants should not assume that limited analyst coverage translates into limited regulatory attention. Limited analyst coverage does not mean limited regulatory attention.

The first 72 hours: what IR does before the 8-K goes out

The first move is assembling a single crisis team, IR, legal, the CFO, audit committee counsel, external communications, so that every subsequent decision runs through one coordinated voice instead of five people improvising in parallel. Splintered messaging in the first 72 hours is often what turns a contained accounting issue into a credibility issue.

Sequencing matters as much as substance. Board and audit committee get briefed first, always. Then comes the harder call: whether major institutional investors and analysts get any advance notice before the 8-K is public, a decision that has to run through Reg FD constraints and can't be treated as a courtesy call IR just decides to make. Rating agencies need notice if debt is affected. Lenders and credit facility counterparties need notice if covenants are at risk. Each of these groups reacts on a different clock, and IR's sequencing plan needs to reflect that before, not during, the scramble.

The 8-K itself, along with any accompanying press release, has to do three things at once: state precisely what's known, acknowledge explicitly what isn't yet known, and lay out what the company is doing about it. Under-disclosure invites suspicion. Premature specificity, guessing at a dollar impact before the audit committee has finished its work, invites a second credibility hit when the number changes. The "do not rely" language is non-negotiable for Big R restatements, legally required, full stop, but IR's actual job is making sure that sentence doesn't become the entire headline. Context around it, not around removing it, is the tool available here.

Messaging principles that hold up across the full duration of the process

Acknowledge before explaining. Investors and analysts consistently extend more patience to companies that lead with the problem than to ones that appear to be managing how the problem looks.

Bound what's known and what isn't, precisely. "We have identified the error, we are quantifying the full impact, and we expect to file restated financials by [date or range]" is a credible sentence because every clause in it is checkable. "We don't anticipate any material impact," offered before the audit committee's work is done, is not credible, because it's a prediction dressed as a fact.

Separate the accounting error from the business. Companies that can draw a clean line between an isolated accounting error and underlying operational performance give investors something to hold onto through the uncertainty. Companies that can't invite the market to start questioning everything, the backlog, the customer relationships, the balance sheet, all of it, because nothing has been ruled out.

Treat remediation as a narrative. The SEC's own enforcement record identifies specific remedial actions companies have taken: replacing senior management, adding accounting staff, amending policies, standing up a disclosure committee, building a related-party transaction review process. Each of those is a communication milestone in its own right.

Managing the institutional investor and analyst relationship through the process

Analysts can't model what they can't measure. In the early phase of a restatement, IR's most valuable job is giving analysts enough structural information, timing, scope, what's still being quantified, to justify holding a placeholder position rather than suspending coverage outright or issuing a blanket downgrade out of sheer uncertainty.

Reaching top holders before the filing goes public, within whatever Reg FD allows, is worth the effort even when the call conveys nothing beyond what the 8-K will say. A direct call from the CFO or the head of IR signals that the company is managing the process rather than being managed by it. Institutions that feel blindsided tend to sell first and ask questions later, and there's no messaging campaign that undoes that first reaction once it's happened.

Earnings calls and investor days during a live investigation need their own protocol. Every anticipated question about the restatement or the inquiry should have a counsel-vetted script, because unscripted answers about ongoing legal matters create new liabilities out of nowhere. The CFO should carry the accounting substance; IR manages pacing and tone across the rest of the call. Investors read silence just as closely as they read statements, so declining to comment on scope or timing, without at least explaining why the company isn't commenting, reads as evasion rather than discipline.

Sophisticated holders won't wait for the company to hand them conclusions. If the restatement touches debt or equity treatment, or revenue recognition, expect institutional investors to go back and re-read prior period disclosures on their own. IR's job is anticipating the specific questions that kind of independent digging is going to surface, and having answers ready before the call, not during it.

What credible remediation looks like and how IR communicates it

The SEC's enforcement record gives IR an actual template to work from. In one settled action that carried no corporate penalty, the remedial steps in that action included replacing senior management officials, increasing accounting staff, amending accounting policies, creating a new process for identifying and disclosing related-party transactions, and establishing a formal disclosure committee. Those are concrete, and they translate into investor language directly.

Leadership changes should be framed as governance strengthening, not confession, unless the underlying facts genuinely require otherwise. Filings and investor calls after standing up a disclosure committee should state that fact in clear terms, because it tells the market that the structure around financial reporting has actually changed, not just the personnel. Policy and process changes need enough specificity for an analyst to judge whether the fix addresses the actual root cause. "Enhanced controls," without more, tells the market nothing and reads as filler.

The restated financials being filed is itself a credibility milestone, arguably the most important one in the whole sequence. The final filing closes the uncertainty that has been sitting on the stock for months, and that resolution is itself a meaningful signal to the market. IR should treat that filing date as a communication event to plan for, not just a compliance deadline to clear off the calendar. A structured post-restatement investor day, where management walks through what happened, what's changed, and why the current numbers can be trusted, is a tool most companies underuse. It's one of the few moments in the entire process where IR gets to set the agenda instead of reacting to someone else's.